ANIP ANI Pharmaceuticals
ANI Pharmaceuticals earnings company data as of 4:47 AM ET 10/6
Scheduled
1 period · newest first · EPS & Rev stacked · nothing reported yet
| Period | Date | Metric | Estimate | Actual | Result |
|---|---|---|---|---|---|
| FY2026 Q3 | 6 Nov | EPS | 1.77 | — | — |
| Rev | — | — | — |
Insider trades
Open-market buys and sales by ANIP's executives, directors and 10% owners, from their Form 4s · last 12 months
- None no insider bought on the open market
- None no sales outside a trading plan
- $208K sold by 1 insider under 10b5-1 plans
-
Stephen P. Carey CFOPlanned sale$208K 2,850 shares at $73.00 1.7% of stakeTraded Sep 29 Filed Sep 30
SEC filings
Recent issuer filings from EDGAR · 9 shown · open Filing / Doc on SEC.gov
Consensus estimates · SEC filings remain the official record · not investment advice